Sanofi S.A. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi S.A. with three other
pharmaceutical manufacturers in Europe:
sales of 39.76 billion Euro [US$51.04 billion]
of which 29%
was Material Science),
Roche Holding Aktiengesellschaft
(45.50 billion Swiss Francs [US$46.81 billion]
of which 77%
was Pharmaceuticals), and
based in the United Kingdom
(£26.43 billion [US$40.11 billion]
of which 81%
During the year ended December of 2012, sales at
Sanofi S.A. were 34.95 billion Euro (US$44.86 billion).
increase of 4.7%
versus 2011, when the company's sales were 33.39 billion Euro.
This was the fourth straight year of sales growth at Sanofi S.A..
Sales of Vaccines saw an increase
that was more than double the company's growth rate: sales were up
12.3% in 2012, from
3.47 billion Euro to 3.90 billion Euro.
Sanofi S.A. also saw significant increases in sales in
Animal Health (up 7.3% to 2.18 billion Euro)